
Experimentica is a contract research organization (CRO) specializing in preclinical ocular models and services for pharmaceutical, biotech, and academic clients globally. Established in 2013, it operates laboratories in Finland and Lithuania and a business development office in France. The company offers end-to-end preclinical ophthalmic services, combining advanced platforms, proprietary algorithms, and AI-driven analysis to support drug development from discovery to clinical stages. Their tailored solutions include disease models, functional assessments, in vivo imaging, molecular biology, and histology, focusing on ocular diseases such as diabetic retinopathy, glaucoma, AMD, dry eye, and retinal ischemia. Experimentica emphasizes scientific excellence, premium quality research, flexibility, and animal welfare, holding AAALAC accreditation. Their expert teams collaborate closely with clients to accelerate ocular drug development with comprehensive data and actionable insights.

Experimentica is a contract research organization (CRO) specializing in preclinical ocular models and services for pharmaceutical, biotech, and academic clients globally. Established in 2013, it operates laboratories in Finland and Lithuania and a business development office in France. The company offers end-to-end preclinical ophthalmic services, combining advanced platforms, proprietary algorithms, and AI-driven analysis to support drug development from discovery to clinical stages. Their tailored solutions include disease models, functional assessments, in vivo imaging, molecular biology, and histology, focusing on ocular diseases such as diabetic retinopathy, glaucoma, AMD, dry eye, and retinal ischemia. Experimentica emphasizes scientific excellence, premium quality research, flexibility, and animal welfare, holding AAALAC accreditation. Their expert teams collaborate closely with clients to accelerate ocular drug development with comprehensive data and actionable insights.